Role of the type I interferons in allograft rejection

Journal of Leukocyte Biology

Volumn 59, Issue 4, 1996, Pages 512-517

  Tovey, Michael G ^a,e   Benizri, Eric ^b   Gugenheim, Jean ^c   Bernard, Ghislaine ^d   Eid, Pierre ^a   Blanchard, Brigitte ^a   Hofman, Paul ^d  

^a UPR 9045   (France)

^b PASTEUR HOSPITAL   (France)

^c University Hospital of Nice University of Nice Sophia Antipolis   (France)

^d INSERM   (France)

^e CNRS   (France)

Author keywords

Cyclosporin A; Immunosuppression; Interferon

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; CYCLOSPORIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL MODEL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029933928     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.59.4.512     Document Type: Review

References (39)

1. Gugenheim, J., Tovey, M., Gigou, M., Crafa, F., Fabiani, B., Reynes, M., Bismuth, H. (1992) Prolongation of heart allograft survival in rats by anti-interferon (IFN) antibodies and low-dose cyclosporine A. Transplant. Int. 5, 460-465.
2. Afifi, M. S., Kumar, V., Bennett, M. (1985) Stimulation of genetic resistance to bone marrow grafts in mice by interferon-α/β. J. Immunol. 134, 3739-3745.
3. Reyes, V. E., Kumpel, G. R. (1987) Interferon α/β synthesis during acute graft-versus-host disease. Transplantation 43, 412-416.
4. Cleveland, M. G., Lane, R. G., Klimpel, G. R. (1987) Enhanced interferon-α/β (IFN-α/β) and defective IFN-γ production in chronic graft versus host disase: a potential mechanism for immunosuppression. Cell. Immunol. 110, 120-130.
5. Uzé, G., Lutfalla, G., Grsser, I. (1990) Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
6. Eid, P., Tovey, M. G. (1995) Characterization of a domain of a human type I interferon receptor protein involved in ligand binding. J. Interferon Res. 15, 205-211.
7. Müller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., Aguet, M. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
8. Benoit, P., Maguire, D., Plavec, I., Kocher, H., Tovey, M., Meyer, F. (1993) A monoclonal antibody to recombinant human IFN-α receptor inhibits biologic activity of several species of human IFN-α, IFN-β, and IFN-ω. Detection of heterogeneity of the cellular type I IFN receptor. J. Immunol. 150, 707-716.
9. Benizri, E. J., Gugenheim, J., Bernard, G., Tovey, M. G. (1995) Role of interferon alpha in allograft rejection. Transplant. Proc. 27, 813-819.
10. Singh, G., Renton, K. W., Stebbing, N. (1982) Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation. Biochem. Biophys. Res. Commun. 106, 1256-1261.
11. van Bekkum, D. W. (1978) The rhesus monkey as a preclinical model for bone marrow transplantation. Transplant. Proc. 10, 105-111.
12. Tsuchida, M., Hirahara, H., Matsumoto, Y., Abo, T., Eguchi, S. (1994) Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor α/β antibody. Transplantation 57, 256-262.
13. Qin, L., Chavin, K. D., Lin, J., Yagita, H., Bromberg, J. S. (1994) Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J. Exp. Med. 179, 341-346.
14. Stevens, H. P. J. D., van der Kwast, T. H., van der Meide, P., Vuzevski, V. D., Buurman, W. A., Jonker, M. (1990) Synergistic immunosuppressive effects of monoclonal antibodies specific for interferon-gamma and tumor necrosis factor alpha. Transplantation 50, 856-861.
15. Nooji, F. J. M., Jonker, M. (1987) The effect on skin allograft survival of a monoclonal specific for a polymorphic CD-3 like cell surface molecule in rhesus monkeys. Eur. J. Immunol. 17, 1089-1093.
16. Northrop, J. P., Ho, S. N., Chen, L., Thomas, D. J., Timmerman, L. A., Nolan, G. P., Admon, A., Crabtree, G. R. (1994). NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369, 497-499.
17. Rao, A. (1994) NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 15, 274-281.
18. Darnell, J. E., Kerr, I. M., Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
19. Levy, D. E. (1995) Interferon induction of gene expression through the Jak-Stat pathway. Semin. Virol. 6, 181-189.
20. Abramovich, C., Shulman, L. M., Ratovitski, E., Harroch, S., Tovey, M., Eid, P., Revel, M. (1994) Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-α and IFN-β. EMBO J. 13, 5871-5877.
21. Cosimi, A. B., Delmonico, F. L., Wright, J. K. (1990) Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 108, 406-413.
22. Delmonico, F. L., Knowles, R. W., Colvin, R. B. (1993) Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. Transplant. Proc. 25, 784-785.
23. Powelson, J. A., Knowles, R. W., Delmonico, F. L., Kawai, T., Mourad, G., Preffer, F. I., Colvin, R. B., Cosimi, A. A. (1994) CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation 57, 788-793.
24. Rebellato, L., Gross, U., Carver, M., Cunningham, P., Riley, R., Ross, W., Knowles, R., Thomas, J. (1993) Treatment of rhesus monkey allograft recipients with a combination of anti-T-cell monoclonal antibodies. Transplant. Proc. 25, 598-599.
25. +, and MHC class II positive cells. Transplant. Proc. 22, 1783-1784.
26. van Bekkum, D. W. (1971) Mitigation of acute GVHD in unrelated bone marrow grafted monkeys. In Manual on Radiation Haematology. Technical Report Series. No. 123, Vienna, IAEA, 317-332.
27. van Putten, L. M., van Bekkum, D. W., De Vries, M. J., Balneb, H. (1967) The effect of preceding blood transfusions on the fate of homologous bone marrow grafts in lethally irradiated monkeys. Blood 30, 749-757.
28. Muller-Bérat, C. N., van Putten, L. M., van Bekkum, D. W. (1972) Cytostatic drugs in the treatment of secondary disease following homologous bone marrow transplantation: extrapolation from the mouse to the primate. Ann. NY Acad. Sci. 340-354.
29. van Bekkum, D. W., Dicke, T. A. (1972) Treatment of immune deficiency disease with bone marrow stem cell concentrates. In Ontogeny of Acquired Immunity, Amsterdam, Elsevier/North-Holland, 223.
30. Neefe, J. R., Merritt, C. B., Vaal, L. (1973) Histocompatibility and bone marrow transplantation between unrelated rhesus monkeys. Transplantation 16, 365-370.
31. Zoumbos, N. C., Gascon, P., Djeu, J. Y., Young, N. S. (1985) Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc. Natl. Acad. Sci. USA 82, 188-192.
32. Foulis, A. K., Farquharson, M. A., Meager, A. (1987) Immunoreactive α-interferon in insulin-secreting β cells in type I diabetes mellitus. Lancet 1423-1427.
33. Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decckker, J. L., Notkins, A. L. (1979) Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301, 5-8.
34. Jones, J. F., Minnich, L. M., Lucas, D. O., Fulginiti, V. A., Ingham, Z., Langford, M. P., Stanton, G. J. (1983) Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenis. J. Clin. Immunol. 3, 14-21.
35. Hopkins, S. J., Meager, A. (1988) Cytokines in synovial fluid : II. The presence of tumour necrosis factor and interferon. Clin. Exp. Immunol. 73, 88-92.
36. Lidven, J. K., Nilsen, R., Bjerke, J. R., Matre, R. (1989) In situ localization of interferons in psoriatic lesions. Arch. Dermatol. Res. 281, 392-397.
37. Schmid, P., Itin, P., Cox, D., McMaster, G. K., Horisberger, M. A. (1994) The type I interferon system is locally activated in psoriatic lesions. J. Interferon Res. 14, 229-234.
38. Traugott, U., Lebon, P. (1988) Multiple sclerosis: Involvement of interferons in lesion pathogenesis. Am. Neurol. 24, 243-251.
39. DeStefano, E., Friedman, R. M., Friedman-Kien, A. E., Goedert, J. J., Henricksen, D., Preble, O. T., Sonnabend, J. A., Vilcek, J. (1982) Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect. Dis. 146, 451-459.